மருந்து ப்ரைஸிஂக் அதிகாரம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மருந்து ப்ரைஸிஂக் அதிகாரம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மருந்து ப்ரைஸிஂக் அதிகாரம் Today - Breaking & Trending Today

Capped: Oximeter, 4 other devices to become cheaper

Capped: Oximeter, 4 other devices to become cheaper
Capped: Oximeter, 4 other devices to become cheaper
Agencies / Updated: Jul 25, 2021, 06:00 IST
Following the capping of prices by the
National Pharmaceutical Pricing Authority (NPPA), 91 per cent brands of five medical devices reported downward revision of prices up to 88 per cent, informed the
Ministry of Chemicals and Fertilizers on Saturday.
The Centre has capped the Trade Margin for five medical devices -
Pulse Oximeter, Blood Pressure Monitoring Machine,
Nebulizer,
MRP was effective from July 20, 2021.
“The margin was capped up to 70 per cent on Price to Distributor (PTD) level. Pursuant there to, a total of 684 products/brands of these medical devices have been reported as on July 23, 2021, and 620 products/brands (91 per cent) have reported downward revision of MRP,” the ministry said. ....

National Pharmaceutical Pricing Authority , Ministry Of Chemicals , Pharmaceutical Pricing Authority , Trade Margin , Blood Pressure Monitoring Machine , Pulse Oximeter , தேசிய மருந்து ப்ரைஸிஂக் அதிகாரம் , அமைச்சகம் ஆஃப் இரசாயனங்கள் , மருந்து ப்ரைஸிஂக் அதிகாரம் , இரத்தம் ப்ரெஶர் கண்காணிப்பு இயந்திரம் ,

GST's anti-profiteering body calls for prioritising consumer complaints on rate cut benefit

GST's anti-profiteering body calls for prioritising consumer complaints on rate cut benefit
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Rajat Bose , Shardul Amarchand Mangaldas , National Pharmaceutical Pricing Authority , National Anti , Standing Committee In Anti , National Anti Profiteering Authority , Standing Committee , Finance Ministry , Pharmaceutical Pricing Authority , Maximum Retail Prices , ராஜாத் போஸ் , ஷார்துள் அமர்சந்த் மங்கல்தாஸ் , தேசிய மருந்து ப்ரைஸிஂக் அதிகாரம் , தேசிய எதிர்ப்பு , நின்று குழு , நிதி அமைச்சகம் , மருந்து ப்ரைஸிஂக் அதிகாரம் , அதிகபட்சம் சில்லறை ப்ரைஸஸ் ,

Government slashes Remdesivir MRP by half, with retro-effect

Government slashes Remdesivir MRP by half, with retro-effect
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

Harsh Vardhan , Narendra Modi , Vinod Tiwari , Uddhav Thackeray , Mansukh Mandaviya , Cipla Ltd , National Pharmaceutical Pricing Authority , Mylan Laboratories Ltd , Hetero Labs Ltd , Syngene International Ltd , Ministry Of Chemicals Fertilisers , Union Ministersdv Sadananda Gowda , Department Of Pharmaceuticals , Crime Branch Of Pune City Police , Central Vigilance Commission , Jubilant Pharma Ltd , Reddy Laboratories Ltd , Cadila Healthcare Ltd , Maximum Retail Price , Barrister Vinod Tiwari , Barrister Tiwari , Laboratories Ltd , Syngene International , Pharmaceutical Pricing Authority , Drugs Price Control Order , Essential Commodities Act ,

NPPA ensured availability of essential drugs during pandemic: Eco Survey

Drug pricing regulator NPPA undertook necessary steps to ensure availability of life saving essential medicines across the country during the COVID-19 pandemic, the Economic Survey said on Friday.
Drug prices in India are regulated to ensure continued availability and affordability of essential medicines with improved access to consumers, it added.
National Pharmaceutical Pricing Authority (NPPA). has played an active role in addressing the exigencies arising out of COVID-19 pandemic and undertook necessary measures to ensure continued availability of life saving essential medicines throughout the country, the survey said.
The regulator invoked extraordinary powers in public interest to ensure that policy enhances access to life saving drugs like Heparin as well as medical oxygen, it added. ....

Department Of Pharmaceuticals , National Pharmaceutical Pricing Authority , Ministerial Empowered Committee , Economic Survey , Pharmaceutical Pricing Authority , Inter Ministerial Empowered Committee , துறை ஆஃப் மருந்துகள் , தேசிய மருந்து ப்ரைஸிஂக் அதிகாரம் , மந்திரி அதிகாரம் பெற்றது குழு , பொருளாதார கணக்கெடுப்பு , மருந்து ப்ரைஸிஂக் அதிகாரம் , இடை மந்திரி அதிகாரம் பெற்றது குழு ,